In fact, in 2022, Nordestgaard and colleagues reported that cholesteryl ester transferase (CETP) deficiency, mimicking pharmacological inhibition of CETP, was associated with a lower cardiovascular morbidity but markedly higher risk of AMD (39, 42, –44). The gene discussed is CETP; the disease is age-related macular degeneration.